AzTrials
AzTrials

Rotator Cuff TendinitisKalklavageNCT05264935

Ultrasound-guided Lavage of Calcific Deposits of the Rotator Cuff

An observational study of Rotator Cuff Tendinitis and Ultrasonography, Interventional, run by Schulthess Klinik at 1 site in Switzerland.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The primary goal of the study is to assess ultrasonographic Power Doppler signals after ultrasound-guided puncture and lavage of rotator cuff calcific tendinitis of the shoulder. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Ultrasound-Guided Puncture and Lavage (UGPL)
Type of treatment
Surgery or procedure
How many people
30 participants
Where
1 siteSwitzerland
Study dates
1 May 2022to 1 Apr 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Adult patients diagnosed with calcific deposit within the rotator cuff of a minimum size of 1.0 x 0.5 x 0.4cm (length x width x depth) and without clear signs of resorption.

Who may be able to join

  • Patient aged 18 years and older
  • Pain in the deltoid region worsening with activities above shoulder level and/or at night with a calcific deposit
  • Ultrasound evaluation of the calcific deposit with type I or II characteristics, a solitary conformation, a minimum size of 1.0 x 0.5 x 0.4cm (length x width x depth) and without clear signs of resorption (PDUS grade 0 - I°, see study procedure).
  • In case of multiple calcific deposits, it has to be warranted that the other deposits are smaller than the minimum size of 1.0 x 0.5 x 0.4cm and with no signs of PDUS signals.
  • Qualification for more intensive treatment on account of no clinical improvement after a minimum of 3 months with conservative treatment (physical therapy and oral anti-inflammatory drugs).
  • able to understand the content of the patient information / consent form in German and give consent to take part in the project

Who cannot join

  • Previous UGPL or surgery of the affected shoulder
  • Treatment with subacromial injection (SAI) or ESWT in the three months before inclusion
  • Other causes of shoulder complaints (e.g. rotator cuff tear, frozen shoulder, inflammatory arthritis, bursitis, …)
  • Intervention failure (no retrieval of calcific material, leakage of the injected saline, disruption of the calcific rim or distribution of calcific material)
  • Patients with a language barrier hindering questionnaire completion
  • Pregnancy

Trial locations and contacts

1 site in 1 country.

Laurent Audigé, Prof contact

+41443857580

forschung.oe@kws.ch

Switzerland1 site, 1 recruiting
  • Schulthess Klinik

    Zurich, 8008

    Stefan Diermayr, Dr, Stefan.Diermayr@kws.ch

    Recruiting

Other trials in Switzerland

About this study

Official title: Ultrasound-guided Lavage of Calcific Deposits of the Rotator Cuff: The Role of Power Doppler Sonography

The primary goal of the study is to assess ultrasonographic Power Doppler signals after ultrasound-guided puncture and lavage of rotator cuff calcific tendinitis of the shoulder. Secondary outcomes are sonographic features like the course of residual calcific material and the course of tendon healing als well as the clinical symptoms of the patient.

Read the detailed description

In our study we investigate the intensity of the power doppler signal after ultrasound-guided puncture and lavage (UGPL) of the rotator cuff calcific tendinitis. We assume that UGPL will lead to intratendinous neovascularisation and that the amount of retrieved calcific material is associated with the PDUS signal. The measurement of the signal will be performed in pre determined time slot for 12 months. Additional we study the correlation between the PDUS signal and the clinical symptoms of the patient and the healing process.

Being tested
Ultrasound-Guided Puncture and Lavage (UGPL)
Keywords
calcific deposit, ultrasound-guided puncture and lavage, power doppler ultrasound
Medical subject headings
Rotator Cuff Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ultrasound-Guided Puncture and Lavage (UGPL)Procedure or surgery

    After local anaesthesia with rapidocain the calcific deposit of the rotator cuff will be punctured and washed out with saline solution.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. PDUS signal intensity

    Power doppler ultrasonography (PDUS) signal intensity

    Measured: One year after intervention

Secondary outcomes (8)
  1. Residual calcific material

    Residual calcific material (constant, decreasing, increasing)

    Measured: One year after intervention

  2. Tendon rupture

    Follow up sonography will be performed to assess the occurrence of tendon rupture, which will be classified as complete, transmural or non transmural

    Measured: One year after intervention

  3. Pain level

    Pain Scale Numeric Rating Scale from 0 (no pain) to 15 (worse pain) as part of the Constant Score

    Measured: One year after intervention

  4. Constant Murley Score (CMS)

    Constant Murley Score (CMS) from 0 (worse) to 100 (better) points

    Measured: One year after intervention

  5. Shoulder function parameters

    Shoulder range of motion (ROM) parameters in degree including elevation (flexion), abduction, and external rotation by 0° abduction measured with a standard goniometter

    Measured: One year after intervention

  6. Shoulder function parameters

    Shoulder strength in 90° abduction position (measured also for the opposite shoulder)(Kg) measured with a spring balance.

    Measured: One year after intervention

  7. Subjective shoulder value (SSV)

    Subjective shoulder value (SSV) is a patient-reported subjective outcome assessing on a scale from 0% (worse) to 100% (best) of normal shoulder condition

    Measured: One year after intervention

  8. Level of improvement

    Patients are reporting separately if the improvement / shoulder status regarding pain, function and quality of life is acceptable (Yes/No) or not for them.

    Measured: One year after intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Mar 2022
  2. Study start1 May 2022
  3. Primary completion1 Apr 2024 (estimated)
  4. Study completion1 Apr 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05264935
Sponsor's protocol ID
OE-0164
Acronym
Kalklavage
Status last verified
Jul 2023
First submitted
8 Feb 2022
Last updated
19 Jul 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Rotator Cuff Tendinitis and Ultrasonography, Interventional, run by Schulthess Klinik at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 19 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Laurent Audigé, Prof (+41443857580, forschung.oe@kws.ch), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

PDUS signal intensity (time frame: One year after intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Jul 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in